Successful Transfer of Umbilical Cord Blood CD34+ Hematopoietic Stem and Progenitor-derived NK Cells in Older Acute Myeloid Leukemia PatientsHarry Dolstra, Nicolaas Schaap, Mieke W.H. Roeven et al.|Clinical Cancer Research|2017Cited by 211
The Rise of Allogeneic Natural Killer Cells As a Platform for Cancer Immunotherapy: Recent Innovations and Future DevelopmentsJohn P. Veluchamy, Jan Spanholtz, Nina Kok et al.|Frontiers in Immunology|2017Cited by 197
In Vivo Efficacy of Umbilical Cord Blood Stem Cell-Derived NK Cells in the Treatment of Metastatic Colorectal CancerJohn P. Veluchamy, James P. Di Santo, Tanja D. de Gruijl et al.|Frontiers in Immunology|2017Cited by 49
Standardized and flexible eight colour flow cytometry panels harmonized between different laboratories to study human NK cell phenotype and functionJohn P. Veluchamy, Jan Spanholtz, María Delso-Vallejo et al.|Scientific Reports|2017Cited by 30
Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutionsNina Kok, Monica Raimo, Zoë Dekkers et al.|Frontiers in Bioengineering and Biotechnology|2025Cited by 7